Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 367, Issue -, Pages 15-17Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2016.04.053
Keywords
Cerebral cavernoma; Intracerebral hemorrhage; Propranolol; Thalidomide; Hemophilia; Willebrand
Categories
Funding
- Bracco
- Roche Diagnostics International AG Switzerland
Ask authors/readers for more resources
Objective: To report a case of a patient with multiple cerebral cavernous malformations (CCM). Observation: A 22 year old man with mild von Willebrand disease presented with two otcipital CCM, one of them with acute hemorrhage. Genetic testing for CCM1-3 did not reveal a mutation. Over a period of 54 months, the patient suffered 26 new CCM hemorrhages despite multiple treatment attempts including thalidomide, simvastatin and hemostatic factors. Only after initiation of propranolol, which has already been successfully used in three children with giant cerebral cavernoma, the occurrence of new CCM with hemorrhages was completely stopped already at dose of 30 mg daily- now for a period of 26 months and without any other medications. Conclusion: This case suggests a protective role for propranolol in preventing the occurrence of new cerebral cavernoma with hemorrhages in adults with multiple CCM. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available